1-8 of 8
Frederick L. Ruberg
Close
Sort by
Journal Articles

Abnormal Global Longitudinal Strain Correlates with Amyloidogenic Light Chain-Induced Cardiac Dysfunction via Direct Myocardial Toxicity in Patients without Significant Amyloid Fibril Deposition

Grace M. Ferri, Josue Villegas Galaviz, Tinuola Ajayi, Richard Giadone, George J. Murphy, Andrew Staron, Frederick L. Ruberg, Vaishali Sanchorawala, Camille V. Edwards
Journal: Blood
Blood (2023) 142 (Supplement 1): 3415.
https://doi.org/10.1182/blood-2023-182520
Published: 2023
Journal Articles

Longitudinal Worsening of Left and Right Sided Cardiac Function in Patients with Sickle Cell Disease

Matthew Spring, Julia Newman, Brittany Scarpato, Rachel Strykowski, Morgan Winburn, Robyn T. Cohen, Frederick L. Ruberg, Seyed Mehdi Nouraie, Elizabeth S. Klings
Journal: Blood
Blood (2023) 142 (Supplement 1): 3876.
https://doi.org/10.1182/blood-2023-182118
Published: 2023
Journal Articles

Outcomes By Cardiac Stage in Newly Diagnosed AL Amyloidosis: Results from Andromeda

Monique C. Minnema, Angela Dispenzieri, MD, Giampaolo Merlini, MD, Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM, Martha Grogan, MD, Ronald Witteles, MD, Frederick L. Ruberg, MD, Mathew S. Maurer, MD, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Arnaud Jaccard, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-139754
Published: 2020
Journal Articles

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

CME Clinical Trials & Observations
Brian Lilleness, Frederick L. Ruberg, Roberta Mussinelli, Gheorghe Doros, Vaishali Sanchorawala
Journal: Blood
Blood (2019) 133 (3): 215–223.
https://doi.org/10.1182/blood-2018-06-858951
Published: 2019
Journal Articles

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Andrew Staron, Lawreen H Connors, Frederick L Ruberg, John L. Berk, Lisa M Mendelson, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5536.
https://doi.org/10.1182/blood-2018-99-112193
Published: 2018
Journal Articles

The Incidence of Atrial Fibrillation Among Patients with AL Amyloidosis Undergoing High Dose Melphalan and Stem Cell Transplantation (HDM/SCT): Experience at a Single Institution

Dina Brauneis, Monica Arun, Frederick L Ruberg, Anthony C Shelton, John Mark Sloan, Karen Quillen, Vaishali Sanchorawala, Cindy Varga
Journal: Blood
Blood (2015) 126 (23): 5490.
https://doi.org/10.1182/blood.V126.23.5490.5490
Published: 2015
Journal Articles

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

Stephanie B. Tsai, David C. Seldin, Karen Quillen, John L. Berk, Frederick L. Ruberg, Hans Meier-Ewert, J. Mark Sloan, Gheorghe Doros, Kathleen T. Finn, Martha Skinner, Vaishali Sanchorawala
Journal: Blood
Blood (2012) 120 (22): 4445–4446.
https://doi.org/10.1182/blood-2012-09-457341
Published: 2012
Journal Articles

High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement

Saulius Girnius, M.D., David C Seldin, MD, PhD, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, John L Berk, MD, Frederick L Ruberg, MD, Hans Meier-Ewert, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2011) 118 (21): 2043.
https://doi.org/10.1182/blood.V118.21.2043.2043
Published: 2011